Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from HUM

Stocks Tumble as Chipmakers Plunge, Oil Spikes

The S&P 500 Index ($SPX ) (SPY ) today is down -0.71%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -1.53%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.98%. September E-mini S&P futures (ESU26 ) are down -0.75%, and September E-mini Nasdaq futures...

Humana Earnings Preview: What to Expect

Humana will release its second-quarter earnings later this month, and analysts anticipate a low single-digit profit dip.

3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound

3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound

Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Is Humana Stock Outperforming the Nasdaq?

Humana has rallied the Nasdaq Composite over the past year, and analysts remain moderately bullish about the stock’s outlook.

Humana Stock Outlook: Is Wall Street Bullish or Bearish?

Humana has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.

Humana Surges Above 50-Day MA. Should You Buy HUM Stock on CMS Rate Changes Here?

Humana shares rally as CMS finalized 2027 Medicare Advantage payments rate at 2.48%. Valuation and options pricing warrant owning HUM shares in 2026.

Is Humana Stock Underperforming the S&P 500?

Humana has notably underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

inkl

Read news from The Economist, FT, and more,
with one subscription

Are Wall Street Analysts Predicting Humana Stock Will Climb or Sink?

Are Wall Street Analysts Predicting Humana Stock Will Climb or Sink?

Humana has notably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Should You Buy the Dip in These 2 Dividend Stocks?

Should You Buy the Dip in These 2 Dividend Stocks?

Tighter Medicare Advantage payment rates are testing two established health insurers, with CVS Health offering a safer dividend entry at 28% upside and 3% yield while Humana's 36% year-over-year decline creates a riskier but potentially stronger bounce-back opportunity if profitability stabilizes faster than the market expects.

These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?

These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?

Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026.

What to Expect From Humana’s Next Quarterly Earnings Report

What to Expect From Humana’s Next Quarterly Earnings Report

Humana has scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a significant loss.

Humana Stock Is Nearly 20% Off Its YTD Highs. Can Mark Cuban Change That?

Humana Stock Is Nearly 20% Off Its YTD Highs. Can Mark Cuban Change That?

Mark Cuban is allegedly looking to partner with Humana on pharmacy offerings.

Adding yet more needless features, Discord joins the 'wrapped' crew with a yearly stat recap called Checkpoint

Adding yet more needless features, Discord joins the 'wrapped' crew with a yearly stat recap called Checkpoint

How Is Humana Stock Performance Compared to Other Healthcare Services Stocks?

How Is Humana Stock Performance Compared to Other Healthcare Services Stocks?

Humana stock has underperformed compared to the healthcare services group, but analysts remain fairly bullish about its prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Is Wall Street Bullish or Bearish on Humana Stock?

Although Humana has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Stocks Rebound on Economic Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.41%. December E-mini S&P futures (ESZ25 ) are up +0.39%, and December E-mini Nasdaq futures...

Humana Q3 Premium Growth Offsets Membership Drop, Stock Tumbles

Humana Inc. (NYSE:HUM) released its third-quarter earnings report on Wednesday, with adjusted earnings of $3.24, exceeding the consensus estimate of $2.82.

Stock Indices Recover Following Sharp Sell-Off on Tuesday

The S&P 500 Index ($SPX ) (SPY ) today is up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Some weaker-than-expected earnings are weighing on technology stocks. Super Micro Computer is down more...

Get all your
news in one place.

100's of premium titles.
One news app.

What to Expect From Humana's Q3 2025 Earnings Report

Humana is scheduled to release its fiscal third-quarter earnings next month, and analysts project a double-digit earnings fall.

S&P 500, Nasdaq 100, Dow, Russell 2000 All Soar To Record Highs: What's Moving Markets Friday

Another historic session is unfolding on Wall Street, where every major index surged to new records by midday trading on Friday, even as Washington's shutdown dragged into its third day.

Darden, Humana, And Rocket Lab Are Among Top 10 Large Cap Losers Last Week (Sep. 15- Sep. 19): Are The Others In Your Portfolio?

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

Humana Stock: Is HUM Underperforming the Healthcare Sector?

While Humana has notably underperformed the broader healthcare sector over the past year, it has outperformed recently, and analysts remain optimistic about the stock’s prospects.

Are Wall Street Analysts Bullish on Humana Stock?

While Humana stock seems to be regaining momentum lately, it is still underperforming the broader market, keeping analysts cautiously optimistic about its prospects.

Humana Boosts 2025 Profit Guidance, Plans $100 Million In Strategic Investments

As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. (NYSE:HUM) is adapting to these changes through strategic adjustments. This adaptability is reflected in their second-quarter earnings report, which exceeded analysts’ expectations despite a decline in adjusted EPS compared to last year.

Humana Moves To Cut Prior Authorization Delays, Streamline Care Approvals

Humana Inc. NYSE: HUM) on Tuesday announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians associated with prior authorization.

1 2 3 4 5

People

206,947 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Supreme Court

Medicare Advantage

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

405,912 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play